Uncategorized
STAT+: FDA appears open to Moderna’s flu vaccine ahead of adcomm
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. Today, one venture capitalist weighs in on the China biotech debate. Let me know if you agree with her or not.
UniQure will submit Huntington’s therapy for approval
The FDA has reversed its opposition to a closely watched experimental treatment for Huntington’s disease, clearing a path for its maker, the biotech company UniQure, to file for U.S. approval, the company said morning.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. Today, one venture capitalist weighs in on the China biotech debate. Let me know if you agree with her or not.
UniQure will submit Huntington’s therapy for approval
The FDA has reversed its opposition to a closely watched experimental treatment for Huntington’s disease, clearing a path for its maker, the biotech company UniQure, to file for U.S. approval, the company said morning.